C. Sandrock, D. Mariano, S. Gelone, G. Moran, G. Waterer, T. M. File
{"title":"Lefamulin对成人社区获得性细菌性肺炎(CABP)的疗效和安全性:Lefamulin对哮喘或慢性阻塞性肺疾病(COPD)患者肺炎(LEAP) 1和LEAP 2试验评价的汇总分析","authors":"C. Sandrock, D. Mariano, S. Gelone, G. Moran, G. Waterer, T. M. File","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3447","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":202379,"journal":{"name":"B97. WHAT'S NEW IN PNEUMONIA","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP): Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Asthma or Chronic Obstructive Lung Disease (COPD)\",\"authors\":\"C. Sandrock, D. Mariano, S. Gelone, G. Moran, G. Waterer, T. M. File\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3447\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":202379,\"journal\":{\"name\":\"B97. WHAT'S NEW IN PNEUMONIA\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B97. WHAT'S NEW IN PNEUMONIA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3447\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B97. WHAT'S NEW IN PNEUMONIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3447","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP): Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Asthma or Chronic Obstructive Lung Disease (COPD)